In addition, the MPG rs2562162 CT+TT genotype exhibited synergistic effects with several clinical factors (hyperlipidemia, smoking, and low prothrombin time levels) (Table 5 and Table S6). This evidence concerns the gene F2 and hyperlipidemia.